In conversation with Dr. Rajnish Tyagi, Founder of Hatvet, he delves into what led him to make his vision come to life and how he continues to advocate for the well being of pets through his work.
Q1. What inspired the founding of Hatvet, and how has the company’s vision evolved since its inception?
Hatvet Pharma was founded by Dr. Rajnish Tyagi, a small animal practitioner with over 20 years of experience. His first hand understanding of the market needs and the challenges faced by veterinary professionals inspired him to create Hatvet. Dr. Tyagi observed gaps in the availability of essential medicines for small animals and sought to address these shortcomings by establishing his own veterinary pharmaceutical company.
Since its inception in 2019, Hatvet Pharma has been driven by a clear vision: to become a leading pharmaceutical company in the veterinary field by providing high-quality, affordable products. The company aims to serve various segments of the pet owner community and is committed to being at the forefront of innovation and quality in the veterinary industry. This vision reflects Hatvet’s dedication to improving the availability and efficacy of veterinary medicines and supporting small animal practitioners with essential solutions.
Q2. Can you share some products that Hatvet has developed, and how they address specific needs in veterinary care?
One of Hatvet Pharma’s leading products is HATPYRIN, which is available in both syrup and tablet forms. Recognizing the potential side effects and contraindications of conventional painkillers and antipyretics in pets—especially cats—Hatvet sought to address these issues with a safer alternative.
HATPYRIN is formulated using a blend of various herbs that provide antipyretic, analgesic, and anti-inflammatory effects. This herbal approach helps to alleviate pain and reduce fever in pets while minimizing the risk of adverse side effects commonly associated with traditional pharmaceuticals. By offering a product that addresses these concerns, Hatvet aims to enhance the well-being of pets and bring comfort to both animals and their owners.
Hatvet Pharma has addressed the challenges of pet bathing in adverse weather conditions and for young, playful puppies with the introduction of their Dry Foam Shampoo. Traditional bathing methods can be cumbersome, particularly during winters, rainy seasons, or when dealing with puppies who frequently get dirty while playing outside.
The HATVET`s Dry Foam Shampoo is designed to simplify pet grooming by reducing the need for water. To use it, you simply apply the foam to your pet’s coat, rub it in, and then wipe it off with a wet towel. This method effectively cleans the coat and imparts a pleasant fragrance, making it easier to maintain your pet’s hygiene and keep them fresh without the hassle of conventional bathing.
Q3. What current trends in the veterinary industry are you most excited about, and how is Hatvet positioning itself to leverage these trends?
In today’s world, pet parents are more informed and conscientious about the products they choose for their pets, akin to how they would select items for their children. This heightened awareness and scrutiny are crucial to the success of Hatvet Pharma.
Hatvet is dedicated to meeting these expectations by prioritizing several key aspects:
Quality of Products: Ensuring that every product meets high standards to provide the best care for pets.
Palatability: Developing products that are not only effective but also appealing to pets, making them easier to administer.
Convenient and Attractive Packaging: Designing packaging that enhances usability and appeals visually to pet owners, reflecting the quality and care embedded in the products.
By aligning with these trends and focusing on these areas, Hatvet aims to build trust with pet parents and contribute positively to their pets’ health and well-being.
Q4. How does Hatvet incorporate feedback from veterinarians and pet owners into its product development process?
Hatvet Pharma employs a centralized sales force model that ensures direct communication between its central office team and veterinarians, the end clients of its products. This approach allows for immediate and transparent feedback—both positive and negative—to be relayed directly to management.
Dr. Rajnish Tyagi, the Managing Director and a practitioner himself, understands the critical importance of addressing negative feedback. He values these insights as opportunities for improvement and swiftly acts on any concerns raised by customers. By addressing issues promptly and implementing remedial steps, Hatvet not only resolves current challenges but also enhances its products and services for the future. This proactive approach helps maintain high standards of customer satisfaction and reinforces the company’s commitment to quality and responsiveness.
Q5. What are some of the biggest challenges Hatvet has faced in the veterinary industry, and how has the company overcome them?
Hatvet Pharma, founded in 2019, faced significant challenges just one year into its inception due to the COVID-19 pandemic. However, the Hatvet team viewed these challenges as opportunities to demonstrate their resilience and commitment.
During this period, the entire Hatvet team rose to the occasion:
Sales Team: Effectively communicated with clients and managed orders despite the difficulties posed by the pandemic.
Billing and Dispatching Team: Worked diligently under adverse health and environmental conditions to ensure the timely delivery of medicines.
Their dedication and hard work during such trying times highlighted Hatvet’s ability to navigate challenges and maintain its service standards, reinforcing their commitment to supporting veterinarians and pet owners even in the most difficult circumstances.
Q6. What advancements do you foresee in the field of veterinary care over the next decade, and how is Hatvet preparing for these changes?
Hatvet Pharma is committed to advancing veterinary care by investing significantly in research and development. This dedication is focused on creating products that are not only beneficial for pets but also prioritize safety for the broader community.
Key areas of this commitment include:
Innovative Research and Development:
Safer Products: Developing new formulations and treatments with an emphasis on safety and efficacy, minimizing potential side effects for pets and reducing risks to pet owners.
Effective Solutions: Creating advanced products that address emerging health challenges in pets, ensuring that they receive the best possible care.
Community Safety:
Environmental Impact: Ensuring that products are environmentally friendly and sustainably produced, contributing to overall community well-being.
Ethical Standards: Adhering to high ethical standards in product development to ensure safety and reduce adverse effects on pets and their owners.
Understanding Future Pet Parents:
Consumer Insights: Researching the preferences and expectations of future generations of pet parents to align product offerings with their needs and values.
Tailored Solutions: Designing products and services that cater to evolving trends and demands in pet care, ensuring relevance and satisfaction among new pet owners.
By focusing on these areas, Hatvet aims to lead the way in creating safer, more effective veterinary products while staying attuned to the needs of both pets and their owners. This forward-thinking approach ensures that Hatvet remains at the forefront of the veterinary industry, providing solutions that meet the highest standards of quality and safety.